Sarepta Therapeutics
SRPT
SRPT
189 hedge funds and large institutions have $1.44B invested in Sarepta Therapeutics in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 77 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 179 → 189 (+10)
3.34% more ownership
Funds ownership: 74.38% → 77.72% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
189
Holding in Top 10
2
Calls
$145M
Puts
$74.3M
Top Buyers
| 1 | +$41.3M | |
| 2 | +$41.2M | |
| 3 | +$19.3M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$18.5M |
| 5 |
HM
HealthCor Management
New York
|
+$16.2M |
Top Sellers
| 1 | -$54.6M | |
| 2 | -$31.2M | |
| 3 | -$23M | |
| 4 |
PP
PDT Partners
New York
|
-$10M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.75M |